MYSTERIOUS: 5 - You Need To See This

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional approval for Calliditas Therapeutics AB's (NASDAQ:CALT) Kinpeygo for primary immunoglobulin A (IgA) nephropathy (IgAN). The opinion covers adult patients at risk of rapid disease progression with a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/gram.  Also See: Calliditas…

From stress to sunlight to hormones, here are five common factors that can contribute to a flare-up of Lupus symptoms.

NEW DELHI: In the last few months, AIIMS has come across at least 30 patients who developed symptoms associated with autoimmune diseases such as rheumatoid arthritis and Sjogren’s syndrome within weeks of getting Covid-19.